Neuren Pharmaceuticals
NEU.AX
$11.81
Share price
-0.19%
Change (1 day)
-49.48%
Change (1 year)
Categories
P/S ratio for Neuren Pharmaceuticals (NEU.AX)
P/S ratio at the end of 2023: 13.9
According to Neuren Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.30. At the end of 2023 the company had a P/S ratio of 13.9.
P/S ratio history for Neuren Pharmaceuticals from 2005 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 13.9 | -80.29% |
| 2022 | 70.5 | |
| 2018 | 10.6 | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2010 | 1.46 | -43.87% |
| 2009 | 2.60 | 130.11% |
| 2008 | 1.13 | -95.9% |
| 2007 | 27.6 | -89.35% |
| 2006 | 259 | 114.05% |
| 2005 | 121 |